rhodamine b has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boase, NR; Coles, DJ; Rolfe, BE; Thurecht, KJ; Veedu, RN | 1 |
| Bello, E; Bigini, P; Colombo, C; D'Incalci, M; Dragoni, L; Falcetta, F; Ferrari, R; Frapolli, R; Licandro, SA; Lupi, M; Morbidelli, M; Moscatelli, D; Salmona, M; Sitia, L; Ubezio, P | 1 |
2 other study(ies) available for rhodamine b and B16 Melanoma
| Article | Year |
|---|---|
Aptamer-targeted hyperbranched polymers: towards greater specificity for tumours in vivo.
Topics: Animals; Aptamers, Peptide; Drug Delivery Systems; Fluorescent Dyes; Injections, Intravenous; Injections, Subcutaneous; Melanoma, Experimental; Methacrylates; Mice; Mice, Inbred C57BL; Molecular Imaging; Polyethylene Glycols; Rhodamines; Skin Neoplasms; Xenograft Model Antitumor Assays | 2013 |
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers; Rhodamines; Tissue Distribution | 2014 |